|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
178,600,000 |
Market
Cap: |
242.90(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.8901 - $1.85 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 7.4 |
Insider 3/6 Months : 8 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Precigen is a clinical-stage biopharmaceutical company improving gene and cell therapies. Co. is utilizing proprietary technology platforms to develop product candidates designed to diseases in its therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Co. is developing its clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. In addition, Co. has completed a Phase 1 study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
96,686 |
1,592,031 |
13,134,243 |
Total Buy Value |
$0 |
$136,327 |
$2,615,293 |
$22,822,494 |
Total People Bought |
0 |
1 |
4 |
8 |
Total Buy Transactions |
0 |
1 |
6 |
12 |
Total Shares Sold |
0 |
96,686 |
455,706 |
505,706 |
Total Sell Value |
$0 |
$136,327 |
$650,097 |
$765,097 |
Total People Sold |
0 |
1 |
6 |
6 |
Total Sell Transactions |
0 |
1 |
21 |
22 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lehr Donald P. |
Chief Legal Officer |
|
2020-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
273,084 |
|
- |
|
Ares Trading S.a. |
10% Owner |
|
2020-10-07 |
4 |
B |
$3.70 |
$24,999,997 |
D/D |
6,758,400 |
27,398,519 |
2.45 |
78% |
|
Kirk Randal J |
Executive Chairman |
|
2020-09-24 |
4 |
A |
$3.50 |
$74,998 |
I/I |
21,428 |
13,517,050 |
|
- |
|
Perez Jeffrey Thomas |
SVP, IP Affairs |
|
2020-09-16 |
4 |
AS |
$5.22 |
$39,985 |
D/D |
(7,660) |
243,229 |
|
63% |
|
Sterling Rick L. |
Chief Financial Officer |
|
2020-09-16 |
4 |
AS |
$5.22 |
$39,985 |
D/D |
(7,660) |
305,313 |
|
63% |
|
Lehr Donald P. |
Chief Legal Officer |
|
2020-09-16 |
4 |
AS |
$5.22 |
$44,234 |
D/D |
(8,474) |
248,084 |
|
63% |
|
Perez Jeffrey Thomas |
SVP, IP Affairs |
|
2020-09-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
250,889 |
|
- |
|
Sterling Rick L. |
Chief Financial Officer |
|
2020-09-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
312,973 |
|
- |
|
Lehr Donald P. |
Chief Legal Officer |
|
2020-09-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
256,558 |
|
- |
|
Kirk Randal J |
Executive Chairman |
|
2020-08-12 |
4 |
B |
$4.26 |
$1,707,689 |
I/I |
400,866 |
220,123 |
2.64 |
128% |
|
Kirk Randal J |
Executive Chairman |
|
2020-08-11 |
4 |
B |
$4.50 |
$3,638,331 |
I/I |
808,518 |
218,459 |
2.64 |
128% |
|
Sabzevari Helen |
President and CEO |
|
2020-07-20 |
4 |
AS |
$4.58 |
$55,968 |
D/D |
(12,220) |
402,145 |
|
64% |
|
Sabzevari Helen |
President and CEO |
|
2020-07-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
414,365 |
|
- |
|
Frank Steven |
Director |
|
2020-06-30 |
4 |
OE |
$3.17 |
$9,409 |
D/D |
2,968 |
265,563 |
|
- |
|
Alvarez Cesar L |
Director |
|
2020-06-23 |
4 |
OE |
$3.17 |
$9,409 |
D/D |
2,968 |
184,133 |
|
- |
|
Mitchell Dean J |
Director |
|
2020-06-19 |
4 |
OE |
$3.17 |
$9,409 |
D/D |
2,968 |
105,441 |
|
- |
|
Lehr Donald P. |
Chief Legal Officer |
|
2020-06-16 |
4 |
AS |
$4.50 |
$37,926 |
D/D |
(8,428) |
231,558 |
|
-4% |
|
Sterling Rick L. |
Chief Financial Officer |
|
2020-06-16 |
4 |
AS |
$4.50 |
$34,286 |
D/D |
(7,619) |
287,973 |
|
-4% |
|
Perez Jeffrey Thomas |
SVP, IP Affairs |
|
2020-06-16 |
4 |
AS |
$4.50 |
$34,286 |
D/D |
(7,619) |
225,889 |
|
-4% |
|
Lehr Donald P. |
Chief Legal Officer |
|
2020-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
239,986 |
|
- |
|
Sterling Rick L. |
Chief Financial Officer |
|
2020-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
295,592 |
|
- |
|
Perez Jeffrey Thomas |
SVP, IP Affairs |
|
2020-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
233,508 |
|
- |
|
Perez Jeffrey Thomas |
SVP, IP Affairs |
|
2020-05-18 |
4 |
AS |
$2.36 |
$134,372 |
D/D |
(56,853) |
208,508 |
|
26% |
|
Sterling Rick L. |
Chief Financial Officer |
|
2020-05-18 |
4 |
AS |
$2.36 |
$134,372 |
D/D |
(56,853) |
270,592 |
|
26% |
|
Lehr Donald P. |
Chief Legal Officer |
|
2020-05-18 |
4 |
AS |
$2.36 |
$148,659 |
D/D |
(62,895) |
214,986 |
|
26% |
|
689 Records found
|
|
Page 12 of 28 |
|
|